CAS number: 50-02-2

General information about the Dexamethasone active pharmaceutical ingredient

Dexamethasone as active pharmaceutical ingredient (API) is a corticosteroid or steroid, class of glucocorticoid. Dexamethasone API used for the treatment of various inflammatory conditions, including bronchial asthma, skin diseases, as well as endocrine and rheumatic disorders. Dexamethasone is commonly utilized for treating eye inflammation caused by allergies. Dexamethasone is available in various forms, including tablets, oral solution, eye drops, ear drops, and injectable solutions. Dexamethasone is available in combination with antibiotics.

Axplora manufactures Dexamethasone API

Dexamethasone API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Dexamethasone API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Dexamethasone API is commercially available as micronised grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Dexamethasone API.
  • Therapeutic area Anti-Inflammatory
  • Monograph USP
  • Available grade Micronized
  • Regulatory documentation EU DMF
    US DMF#
  • Produced in GRO